Literature DB >> 6816269

Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma.

E Koren, W J McConathy, P Alaupovic.   

Abstract

Apolipoprotein F (ApoF), one of the minor apolipoproteins in human plasma, has been recently isolated and partially characterized [Olofsson, S.O., McConathy, W.J., & Alaupovic, P. (1978) Biochemistry 17, 1032-1036]. In the present work, the interaction of ApoF with other apolipoproteins and lipids in human plasma was studied. By the successive use of immunosorbers specific for ApoF, apolipoprotein A-II (ApoA-II) and apolipoprotein A-I (ApoA-I), three different ApoF-containing lipoproteins were isolated from normolipidemic fasting human plasma. Their apolipoprotein content was determined by double immunodiffusion against monospecific antisera to all known serum apolipoproteins, electroimmunoassay, crossed immunoelectrophoresis, and polyacrylamide gel electrophoresis. Their lipid composition was determined by thin-layer chromatography. The three ApoF-containing lipoproteins were identified as LpF:A-I:A-II (lipoprotein containing ApoF, ApoA-I, and ApoA:II), LpF:A-I (lipoprotein containing ApoF and ApoA-I), and LpF (lipoprotein containing only ApoF). LpF:A-I:A-II was found to contain ApoF, ApoA-I, and ApoA-II in an apparent 2:1:1 molar ratio. Its lipid moiety was characterized by cholesterol ester (45%) and free cholesterol (28%) as the predominant lipids. LpF contained only ApoF, and in its major lipid components were also cholesterol esters (63%) and free cholesterol (21%). It is suggested that ApoF-containing lipoproteins may be involved in transport and/or esterification of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6816269     DOI: 10.1021/bi00264a035

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.

Authors:  Yan Liu; Richard E Morton
Journal:  Curr Opin Lipidol       Date:  2020-08       Impact factor: 4.776

2.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

3.  Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.

Authors:  Kaijin Wu; Corrine Joffre; Xiaodong Li; Michelle MacVeigh-Aloni; Melinda Hom; Juliana Hwang; Chuanqing Ding; Stephane Gregoire; Lionel Bretillon; Jiang F Zhong; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2009-04-02       Impact factor: 3.467

4.  Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo.

Authors:  William R Lagor; Robert J Brown; Sue-Anne Toh; John S Millar; Ilia V Fuki; Margarita de la Llera-Moya; Tiffany Yuen; George Rothblat; Jeffrey T Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-13       Impact factor: 8.311

5.  The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.

Authors:  William R Lagor; David W Fields; Sumeet A Khetarpal; Arthi Kumaravel; Wen Lin; Nathaniel Weintraub; Kaijin Wu; Sarah F Hamm-Alvarez; Denise Drazul-Schrader; Margarita de la Llera-Moya; George H Rothblat; Daniel J Rader
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

6.  LXR/RXR signaling and neutrophil phenotype following myocardial infarction classify sex differences in remodeling.

Authors:  Kristine Y DeLeon-Pennell; Alan J Mouton; Osasere K Ero; Yonggang Ma; Rugmani Padmanabhan Iyer; Elizabeth R Flynn; Ingrid Espinoza; Solomon K Musani; Ramachandran S Vasan; Michael E Hall; Ervin R Fox; Merry L Lindsey
Journal:  Basic Res Cardiol       Date:  2018-08-21       Impact factor: 17.165

7.  Glycoproteomic Profiling Provides Candidate Myocardial Infarction Predictors of Later Progression to Heart Failure.

Authors:  Kristine Y Deleon-Pennell; Osasere K Ero; Yonggang Ma; Rugmani Padmanabhan Iyer; Elizabeth R Flynn; Ingrid Espinoza; Solomon K Musani; Ramachandran S Vasan; Michael E Hall; Ervin R Fox; Merry L Lindsey
Journal:  ACS Omega       Date:  2019-01-15

8.  Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma.

Authors:  Ya-Bin Wang; Bo-Xuan Zhou; Yun-Biao Ling; Zhi-Yong Xiong; Rui-Xi Li; Yue-Si Zhong; Ming-Xing Xu; Yi Lu; Hao Liang; Gui-Hua Chen; Zhi-Cheng Yao; Mei-Hai Deng
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-04-21

9.  Identification of modules and hub genes associated with platinum-based chemotherapy resistance and treatment response in ovarian cancer by weighted gene co-expression network analysis.

Authors:  Luoyan Zhang; Xuejie Zhang; Shoujin Fan; Zhen Zhang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.